SOME REMARKS ON THE PROBABILITY OF GENERATING AN ALMOST SIMPLE GROUP

n/

The history of Lake Maggiore industrial pollution traced through lake sediment and long term monitoring of the biota

In Lake Maggiore large watershed (ca. 6,600 sq. km), industrial activities along the XX century led to the discharge into the lake or its tributaries of several pollutants, such as DDT, PCBs and mercury. Other pollutants, such as PAHs and flame retardants (such as PBDEs) are still reaching the lake. Analyses of some of these pollutants in lake biota were performed continuously since 1998 and form a unique time series. We used in parallel lake sediment cores to infer the history of lake contamination, and analyses of biological samples to describe the distribution of these pollutants in the lake food web and its year-to-year variability. Furthermore, analysis of the sediment of the main rivers flowing towards Lake Maggiore was used to get information on present sources of pollution. Results also show that legacy pollutants, which are no more used nor produced, still reach the lake from polluted soils located around the industrial sites, in particular during heavy rainfall. In particular, we paid special attention to Hg and to DDT and its metabolites, because of the presence of a large pollution source close to the River Toce, one of the main inlets of Lake Maggiore. Although DDT production ended in 1996, p,p\u27-DDT is still found in river sediment and in molluscs collected in Lake Maggiore, deriving probably from polluted soils. On the contrary, p,p\u27-DDE prevails in fish tissues, zooplankton and molluscs. Finally, high values of the concentration of some pollutants in the sediment of Lake Maggiore outlet (River Ticino) show that the lake does not act as a perfect sink for these compounds. Considering present day pollution, PAHs derive from diffuse sources and are found in the sediment of all tributaries, while PBDEs where found only in the sediment of two inlets, revealing the presence of active point sources

Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib

Background/aim: Single-agent tyrosine kinase inhibitors are still prescribed as first-line treatment to a relevant subgroup of patients with metastatic renal cell carcinoma (mRCC). These agents are known to cause disfunction of many endocrine glands (e.g., thyroid). In this two-step trial, we aimed to assess gonadal function among male patients with mRCC treated with sunitinib. Patients and methods: We enrolled a first cross-sectional cohort of pre-treated (>6 months) patients and a subsequent cohort of treatment-naïve patients who were prospectively followed-up. All patients were screened for hypogonadism and received a Functional Assessment of Cancer Therapy - General (FACT-G) questionnaire at study entry and after 6 months of therapy. Patients who were candidates for testosterone replacement therapy (TRT) also received a FACT-G questionnaire at baseline and 3 months after supplementation. Results: Among the 30 enrolled patients, the prevalence of hypogonadism was found to be higher in those receiving sunitinib for a longer period (27.3% at baseline, 41.7% in the first 6 months, and 68.4% after 9 months of therapy). The testosterone level of patients correlated with quality of life (R=0.32). A total of six patients received TRT, with a significant improvement in their global quality of life after the first 3 months of treatment. Conclusion: An increasing prevalence of hypogonadism was seen among male patients who received long-term treatment with sunitinib. TRT was associated with relevant improvements in quality of life. These findings corroborate similar published observations and encourage the assessment of gonadal function in male patients with mRCC under treatment with sunitinib

HEART-RATE-VARIABILITY IN PATIENTS WITH ORTHOTOPIC HEART-TRANSPLANTATION - LONG-TERM FOLLOW-UP

To evaluate heart rate variability (expressed as the standard deviation of RR intervals) within 5 years of follow-up, we studied 20 patients (14 males, 6 females, mean age 44 +/- 12 years) who underwent orthotopic heart transplantation. Six measurements were taken: one in the first 3 weeks after transplantation, and the others once annually, for 5 years. Twenty healthy subjects (mean age 44 +/- 7 years) constituted the control group. Heart rate variability increased significantly in the first 3 years of follow-up (7.2 +/- 1 vs. 11.1 +/- 4, p0.001; 11.1 +/- 4 vs. 15.2 +/- 4, p0.01; 15.2 +/- 4 vs. 18.9 +/- 5, p0.05); in the following years this trend slackened and values did not reach a statistically significant difference (18.9 +/- 5 vs. 21.4 +/- 5; 21.4 +/- 5 vs. 22.5 +/- 5). The mean standard deviation was invariably greater in the control group (63.6 +/- 12). These findings show that sinus rhythm variability in the denervated heart progressively increased over 5 years of follow-up. The absence of presynaptic uptake, which is responsible for adrenergic hypersensitivity to circulating catecholamines and intrinsic cardiac reflexes, does not appear to cause this phenomenon, since these mechanisms are not able to evolve in time after cardiac transplantation. Therefore, an enhanced beta-adrenergic receptors density or affinity to circulating catecholamines or a limited sympathetic reinnervation may be the more probable underlying mechanism

Oncological treatment administration at end of life: a retrospective study

Background: This work evaluated the proportion of patients who continue therapy until their last month of life or initiate a new therapy in the last 3 months of life (end of life [EOL]). Methods: Data for 486 patients were retrospectively collected. Results: In EOL, 205 (42.3%) received systemic therapy. Better performance status (last month OR: 0.39; 95% CI: 0.25-0.60; p < 0.001; last 3 months OR: 0.47; 95% CI: 0.34-0.65; p < 0.001) and lack of activation of palliative care (last month OR: 0.26; 95% CI: 0.13-0.54; p < 0.001; last 3 months OR: 0.18; 95% CI: 0.10-0.32; p < 0.001) were associated with higher probability of EOL therapy. Conclusion: A non-negligible proportion of patients in real-life settings continue to receive systemic treatment in EOL

Progetto "Acque pulite"

Abstract not availableLe aree montane, soprattutto in territori ricchi di acqua come quello del Verbano Cusio Ossola e del bacino del Lago Maggiore, sono da sempre oggetto di utilizzo per la produzione di energia elettrica da fonti rinnovabili, principalmente attraverso impianti idroelettrici. Il giusto equilibrio tra il mantenimento della qualit? ecologica degli ecosistemi torrentizi e la produzione di energia elettrica da fonti rinnovabili non ? di facile attuazione, soprattutto in assenza di studi e sperimentazioni dedicate. Lo sfruttamento delle acque a scopo idroelettrico pu? determinare l\u27alterazione e, a volte, la perdita di habitat, causando una riduzione della biodiversit?, con effetti negativi maggiori sui taxa pi? sensibili (ad esempio macroinvertebrati e fauna ittica), causando contestualmente, il degrado della qualit? ecologica di parte o addirittura dell\u27intero corso d\u27acqua a seconda delle tipologie di prelievo/i a cui ? stato sottoposto. Diventa quindi importante, nel contesto locale, ma anche nazionale e internazionale, dove le energie rinnovabili sono un punto focale per la futura produzione di energia, trovare il giusto equilibrio tra la qualit? ecologica degli ecosistemi, e la richiesta di energia pulita e di sviluppo economico. E\u27 proprio in questo contesto che nasce l\u27idea del Progetto "Acque Pulite", che grazie alla disponibilit? e al finanziamento di IDROENERGY S.r.l. ha visto la realizzazione di uno studio pilota sul Torrente San Giovanni. Il Torrente San Giovanni ? uno dei principali immissari del Lago Maggiore e per tale motivo risulta importante conoscere la sua qualit? ecologica e gli effetti su di essa delle diverse attivit? umane che insistono all\u27interno del suo bacino. In particolare, con il Progetto "Acque Pulite" si sono voluti verificare gli effetti della presenza di un\u27opera di presa e di una traversa, costruite per scopo idroelettrico, sulla qualit? idro-morfologica, chimica e biologica dei tratti di torrente a monte e a valle di tali opere

Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations

Details of sequence profiles for each NCWS subject. (XLSX 47 kb

Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study

Background: Among its extragonadal effects, follicle-stimulating hormone (FSH) has an impact on body composition and bone metabolism. Since androgen deprivation therapy (ADT) has a profound impact on circulating FSH concentrations, this hormone could potentially be implicated in the changes of fat body mass (FBM), lean body mass (LBM), and bone fragility induced by ADT. The objective of this study is to correlate FSH serum levels with body composition parameters, bone mineral density (BMD), and bone turnover markers at baseline conditions and after 12 months of ADT. Methods: Twenty-nine consecutive non-metastatic prostate cancer (PC) patients were enrolled from 2017 to 2019 in a phase IV study. All patients underwent administration of the luteinizing hormone-releasing hormone antagonist degarelix. FBM, LBM, and BMD were evaluated by dual-energy x-ray absorptiometry at baseline and after 12 months of ADT. FSH, alkaline phosphatase, and C-terminal telopeptide of type I collagen were assessed at baseline and after 6 and 12 months. For outcome measurements and statistical analysis, t-test or sign test and Pearson or Spearman tests for continuous variables were used when indicated. Results: At baseline conditions, a weak, non-significant, direct relationship was found between FSH serum levels and FBM at arms (r = 0.36) and legs (r = 0.33). Conversely, a stronger correlation was observed between FSH and total FBM (r = 0.52, p = 0.006), fat mass at arms (r = 0.54, p = 0.004), and fat mass at trunk (r = 0.45, p = 0.018) assessed after 12 months. On the other hand, an inverse relationship between serum FSH and appendicular lean mass index/FBM ratio was observed (r = -0.64, p = 0.001). This is an ancillary study of a prospective trial and this is the main limitation. Conclusions: FSH serum levels after ADT could have an impact on body composition, in particular on FBM. Therefore, FSH could be a promising marker to monitor the risk of sarcopenic obesity and to guide the clinicians in the tailored evaluation of body composition in PC patients undergoing ADT. Funding: This research was partially funded by Ferring Pharmaceuticals. The funder had no role in design and conduct of the study, collection, management, analysis, and interpretation of the data and in preparation, review, or approval of the manuscript. Clinical trial number: clinicalTrials.gov NCT03202381, EudraCT Number 2016-004210-10